Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/22 17:19 | 8/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Usman Nassim | CA | DO | P,CEO | P | 2 | 0.4700 | 0 | 3 | 11 | 34 | D | ||||||||||||||
8/10/22 17:19 | 8/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Miller Seline E. | CA | O | SVP Fina | P | 2 | 0.4700 | 0 | 3 | 100 | 7 | D | ||||||||||||||
8/10/22 17:17 | 8/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Blouse Grant E. | CA | O | Chief Sc | P | 2 | 0.4700 | 0 | 3 | 53 | 9 | D | ||||||||||||||
2/16/22 20:13 | 2/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Usman Nassim | CA | DO | P,CEO | P | 1 | 0.4600 | 0 | 3 | 12 | 31 | D | ||||||||||||||
2/16/22 20:10 | 2/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Miller Seline E. | CA | O | SVP Fina | P | 1 | 0.4600 | 0 | 3 | New | 3 | D | ||||||||||||||
2/16/22 20:07 | 2/9/22 | CBIO | Health | Drug | Pharmaceutical Preparations | Blouse Grant E. | CA | O | Chief Sc | P | 1 | 0.4600 | 0 | 3 | 111 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |